Trials / Conditions / Extensive Disease Small Cell Lung Cancer

Extensive Disease Small Cell Lung Cancer

4 registered clinical trials studyying Extensive Disease Small Cell Lung Cancer — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Sintilimab Combined With Tafolecimab and Chemotherapy as First-Line Treatment for Extensive-Stage Small Cell L NCT07061535	Second Affiliated Hospital, School of Medicine, Zhejiang University	Phase 2
Completed	The Biomarker Exploratory Study in Prospective Multicenter Observational Study of Atezolizumab Combination The NCT04818983	Chugai Pharmaceutical	—
Completed	Prospective Multicenter Observational Study of Atezolizumab Combination Therapy in Lung Cancer (J-TAIL-2) NCT04501497	Chugai Pharmaceutical	—
Completed	Sintilimab Combined With Anlotinib as Second or Further-line Therapy for ED-SCLC NCT04055792	Henan Cancer Hospital	Phase 2